Extendicare Stock Performance
| EXE Stock | CAD 24.15 0.34 1.39% |
On a scale of 0 to 100, Extendicare holds a performance score of 13. The firm shows a Beta (market volatility) of -0.52, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Extendicare are expected to decrease at a much lower rate. During the bear market, Extendicare is likely to outperform the market. Please check Extendicare's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Extendicare's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Extendicare are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Extendicare displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 75.2 M | |
| Total Cashflows From Investing Activities | -9.1 M |
Extendicare |
Extendicare Relative Risk vs. Return Landscape
If you would invest 2,047 in Extendicare on November 28, 2025 and sell it today you would earn a total of 368.00 from holding Extendicare or generate 17.98% return on investment over 90 days. Extendicare is generating 0.2849% of daily returns assuming 1.661% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Extendicare, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Extendicare Target Price Odds to finish over Current Price
The tendency of Extendicare Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 24.15 | 90 days | 24.15 | about 13.9 |
Based on a normal probability distribution, the odds of Extendicare to move above the current price in 90 days from now is about 13.9 (This Extendicare probability density function shows the probability of Extendicare Stock to fall within a particular range of prices over 90 days) .
Extendicare Price Density |
| Price |
Predictive Modules for Extendicare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Extendicare. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Extendicare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Extendicare is not an exception. The market had few large corrections towards the Extendicare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Extendicare, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Extendicare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.33 | |
β | Beta against Dow Jones | -0.52 | |
σ | Overall volatility | 1.30 | |
Ir | Information ratio | 0.1 |
Extendicare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Extendicare Stock often depends not only on the future outlook of the current and potential Extendicare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Extendicare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 95.4 M | |
| Cash And Short Term Investments | 121.8 M |
Extendicare Fundamentals Growth
Extendicare Stock prices reflect investors' perceptions of the future prospects and financial health of Extendicare, and Extendicare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Extendicare Stock performance.
| Return On Equity | 0.66 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.49 B | ||||
| Shares Outstanding | 94.46 M | ||||
| Price To Earning | 26.74 X | ||||
| Price To Book | 8.56 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 1.47 B | ||||
| EBITDA | 155.27 M | ||||
| Cash And Equivalents | 121.85 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 292.49 M | ||||
| Debt To Equity | 6.07 % | ||||
| Book Value Per Share | 1.96 X | ||||
| Cash Flow From Operations | 143.64 M | ||||
| Earnings Per Share | 1.06 X | ||||
| Total Asset | 719.79 M | ||||
| Retained Earnings | (352.55 M) | ||||
| Current Asset | 211.37 M | ||||
| Current Liabilities | 218.02 M | ||||
About Extendicare Performance
By examining Extendicare's fundamental ratios, stakeholders can obtain critical insights into Extendicare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Extendicare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Extendicare Inc. provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. EXTENDICARE INC operates under Medical Care Facilities classification in Canada and is traded on Toronto Stock Exchange. It employs 22800 people.Things to note about Extendicare performance evaluation
Checking the ongoing alerts about Extendicare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Extendicare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Extendicare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Extendicare's stock performance include:- Analyzing Extendicare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Extendicare's stock is overvalued or undervalued compared to its peers.
- Examining Extendicare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Extendicare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Extendicare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Extendicare's stock. These opinions can provide insight into Extendicare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.